Vaccination with tumor-ganglioside glycomimetics activates a selective immunity that affords cancer therapy
Vaccination with tumor-ganglioside glycomimetics activates a selective immunity that affords cancer therapy
Download | |
---|---|
DOI | Resolve DOI: https://doi.org/10.1016/j.chembiol.2019.03.018 |
Author | Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: |
Affiliation |
|
Format | Text, Article |
Subject | ganglioside; glycomimetic; immunity; vaccine; cancer therapy |
Abstract | |
Publication date | 2019-05-16 |
Publisher | Elsevier Cell Press |
Licence |
|
In | |
Language | English |
Peer reviewed | Yes |
NRC number | NRC-HHT_53421 |
Export citation | Export as RIS |
Report a correction | Report a correction (opens in a new tab) |
Record identifier | 20aa9f9e-4b76-4246-8cb4-3dd6e091ba2a |
Record created | 2020-12-08 |
Record modified | 2021-09-24 |
- Date modified: